Managed care pharmacists are involved formally with the interface between the delivery and financing of health care; their work thus entails an accountability for both elements. Interpreted broadly, managed care pharmacists are pharmacists working within the sphere of a health care system, health care purchaser, health insurer, managed care organization, or benefit administration agency. Patients, the pharmacy profession, and society are best served by this broad interpretation, because the interdependency of financing and delivery is inextricably linked to the achievement of good health outcomes. This continuing feature will explore contemporary issues facing managed care pharmacists.
Get full access to this article
View all access options for this article.
References
1.
Evidence Based Medicine Working Group.Evidence-based medicine: A new approach to teaching the practice of medicine.JAMA.1992; 268: 2420–5.
2.
RosenbergW., DonaldA.Evidence based medicine: An approach clinical problem solving.BMJ.1995; 310: 1122–6.
3.
IsaacsD., FitzgeraldD.Seven alternatives to evidence based medicine.BMJ.1999; 319: 1618.
4.
DanielsN., SabinJ.E.Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers.Philos Public Aff.1997; 26(4): 303–50.
5.
EmanuelE.J.Justice and managed care: Four principles for the just allocation of health care resources.Hastings Center Report.2000; 30(3): 8–16.
DanielsN., SabinJ.E.Setting Limits Fairly: Can We Learn to Share Medical Resources?New York: Oxford University Press;2002.
8.
MorganrothJ., LichsteinE., ByingtonR.Beta-Blocker Heart Attack Trial: Impact of propranolol therapy on ventricular arrhythmias.Prev Med.1985; 14(3): 346–57.
9.
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).Lancet.1994; 344: 1383–9.
10.
KleimanN.S., LincoffA.M., FlakerG.C.Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes.Circulation.2000; 101(7): 751–7.
11.
LasserK.E., AllenP.D., WoolhandlerS.J.Timing of new black box warnings and withdrawals for prescription medications.JAMA.2002; 287: 2215–20.
